tradingkey.logo

NewGenIvf Group Ltd

NIVF
View Detailed Chart
0.634USD
+0.025+4.11%
Close 11/04, 16:00ETQuotes delayed by 15 min
548.35KMarket Cap
LossP/E TTM

NewGenIvf Group Ltd

0.634
+0.025+4.11%
Intraday
1m
30m
1h
D
W
M
D

Today

+4.11%

5 Days

-46.27%

1 Month

-65.54%

6 Months

-78.94%

Year to Date

-99.22%

1 Year

-99.53%

View Detailed Chart

TradingKey Stock Score of NewGenIvf Group Ltd

Currency: USD Updated: 2025-11-04

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered undervalued,and institutional recognition is low. Over the past 30 days, multiple analysts have rated the company as a .

NewGenIvf Group Ltd's Score

Industry at a Glance

Industry Ranking
66 / 78
Overall Ranking
529 / 4616
Industry
Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
15.000
Target Price
+2363.05%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

NewGenIvf Group Ltd Highlights

StrengthsRisks
NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. The Company offers services, such as Mitochondrial Replacement Therapy In Reproductive, Intrauterine Insemination (IUI), Mitochondrial replacement therapy (MRT) techniques, In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI), semen analysis, testicular / epididymal sperm aspiration or extraction / percutaneous epididymal sperm aspiration, embryo transfer, chromosome screening and egg freezing. The Company’s clinics are located in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. MRT involves an additional egg from a third person, and manipulating both the recipient egg and the donor egg.
Growing
The company is in a growing phase, with the latest annual income totaling USD 5.43M.
Turnaround to Loss
The company's performance has turned to a loss, with the latest annual loss of USD .
Fairly Valued
The company’s latest PE is 0.02, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 5.48K shares, increasing 22.58% quarter-over-quarter.
Held by Howard Marks
Star Investor Howard Marks holds 0.00 shares of this stock.

NewGenIvf Group Ltd News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

NewGenIvf Group Ltd Info

NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. The Company offers services, such as Mitochondrial Replacement Therapy In Reproductive, Intrauterine Insemination (IUI), Mitochondrial replacement therapy (MRT) techniques, In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI), semen analysis, testicular / epididymal sperm aspiration or extraction / percutaneous epididymal sperm aspiration, embryo transfer, chromosome screening and egg freezing. The Company’s clinics are located in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. MRT involves an additional egg from a third person, and manipulating both the recipient egg and the donor egg.
Ticker SymbolNIVF
CompanyNewGenIvf Group Ltd
CEOMr. Siu (Alfred) Wing Fung
Websitehttps://newgenivf.com/
KeyAI